Replies to post #375574 on Amarin Corp Plc (AMRN)

[FlyFishingStocks]

Oh come on Margin requirements for one thing are far more restrictive now then in 1929

"The fortunate speculator who had funds to answer the first margin call presently got another and equally urgent one, and if he met that there would still be another. In the end all the money he had was extracted from him and lost. The man with the smart money, who was safely out of the market when the first crash came, naturally went back in to pick up bargains.

The bargains then suffered a ruinous fall. Even the man who waited out all of October and all of November, who saw the volume of trading return to normal and saw Wall Street become as placid as a produce market, and who then bought common stocks would see their value drop to a third or a fourth of the purchase price in the next twenty-four months."
--John Kenneth Galbraith, The Great Crash of 1929

I wish you the best with your buying. Prof Jermey Seigal ( Wharton ) and Tom Lee's (CNBC contributor) will be proud of you.

...and the music played on

[JRoon71]

Oh come on Margin requirements for one thing are far more restrictive now then in 1929
Spreading fear FFS ?…. I’ll have to keep buying .
Bt yesterday at $2.94
If AMRN tests the PPS pts you posted today I’ll buy more
Kiwi

Not to mention, at AMRN's market cap, any time the price goes much lower, there are so many bottom dwellers (meant in an affectionate way!) willing to buy that value.

It's not like we're talking about a trillion dollar company that's overvalued like Tesla. We're talking about a company that is UNDERvalued, and barely scraping $1B (LESS, if you factor CoH). That's loose change for some institutions, which is one reason I can't wrap my head around why there have not been more institutional buyers at these prices. Maybe the Street just lost interest because it's evolving too slow, or went full stop at seeing "...lost U.S. patents" headlines all over the place. It's definitely a head scratcher.

But when you really dig in, the risk/reward ratio on AMRN is wildly in favor of investment. This is why I stay in it, despite my "devil's advocate" stance sometimes. I just feel like there is a floor in this stock because it's a proven, legitimate drug that is already actively being marketed and sold (OK, with "air quotes" around "marketed" )

But despite there being (what I believe) to be a solid floor, the potential upside is relatively uncapped, depending on how this plays out. So I feel like I could make a little, or a LOT, with very little downside (from HERE).